Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications.
about
Clinical significance of hepatitis C virus genotypesComparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.Hepatitis C Virus Subtyping by a Core-Envelope 1-Based Reverse Transcriptase PCR Assay with Sequencing and Its Use in Determining Subtype Distribution among Danish PatientsComplement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoproteinGenotyping of hepatitis C virus isolates from Basque Country, SpainGreater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland ChinaSecond-generation line probe assay for hepatitis C virus genotypingDiscordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regionsHepatitis C virus detection by single-round PCR specific for the terminal 3' noncoding regionDetermination of genotypes of hepatitis C virus in Venezuela by restriction fragment length polymorphismGlobal epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypesNested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypesMolecular methods of hepatitis C genotyping.A simple real-time polymerase chain reaction assay using SYBR Green for hepatitis C virus genotyping.Cellular immune response to infection by different genotypes of hepatitis C virus.Genotypic analysis of hepatitis C virus in khuzestan province, southwestern iran.Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study.At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C.Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells.Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group.Evaluation of two simplified methods for genotyping hepatitis C virus.Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence.GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors.Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response.Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate.Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides.Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997).Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission.Progression of fibrosis in untreated patients with hepatitis C virus infection.Acute nosocomial HCV infection detected by NAT of a regular blood donor.Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease.Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.
P2860
Q24514512-BB672A5A-5429-4828-9D48-BC18ED30450CQ27473052-DD218F44-55EE-4B5B-B064-D77E326B7B2EQ27473362-2CE0A19E-51BF-4937-AA1A-F806406926A1Q27473461-B54440A5-AA68-47A6-B7F3-7E39B13A4C00Q27485608-CCA24CC1-88F8-4E17-B173-3B0B25825F2DQ27485672-46CEBA30-14D6-431A-8381-39934ED2BE8FQ27485722-954ED3D3-37AB-490D-9103-57D0EC87B1C9Q27485741-62DCB492-D14B-461C-A9B9-E506C5BD8C26Q27485752-482961B6-EB6C-4149-9AE3-EB89C1FF76FDQ27485782-9532BED2-8F5C-4779-8952-868278574CBAQ30245058-2857DDBC-2673-4E1D-8725-3D50D39F51DFQ33972205-0E0C59A3-4CA3-4EFF-8DE4-214B0F8C6549Q36192689-D60BBEAE-4C14-4159-959D-87E46857BB4AQ40528954-8466738A-9F4B-4D0B-99E0-06AEA0DECEBAQ42181529-F00C5372-449B-4D84-A0F3-BB8224C325B7Q42251718-F6692233-C69C-4C82-A22D-AD8103E6EDD6Q42631714-13DB9DCF-7031-4439-980C-B3B408D828ABQ42631724-09179D52-A6E8-4896-AF9B-A8E176AE1BEFQ42654339-CA6800F1-5C70-419A-9B4A-54911CEC5842Q42978426-968D8468-AD34-48CF-BD5E-6EAC336414BCQ42979805-494DFCEA-80E0-46FD-896D-06B8FA1E88C9Q42982618-9F145F5F-D1D0-4978-A470-0A72DC4C2B98Q42986748-06279973-6579-4A88-A5CC-2A13E34765CDQ42986809-24B9CACB-C684-405C-B442-D8D5A108246DQ43030170-79FE5F47-5E6B-492F-BAF1-B3D4EB5085CDQ43030249-FA901EE3-0031-4BCE-99DD-C5B8ADB7907CQ43035983-8CBBC996-5BFE-4B2F-BBC4-37E00FE91A98Q43037115-0A694E35-C26F-482C-9066-E5D1F46B80DCQ43037248-441C7CB0-B733-4140-AA59-9EA6AD11C2CDQ43037975-8FF6BC4F-5C4A-4115-BEC1-30880FF860EBQ43039282-F7E28732-0D6B-4184-96DE-0EEB49258156Q43047091-49526329-30A2-48EF-8877-3C6E89616A40Q43767234-C55F6AB7-80F1-4C4A-A856-709BDC6E3D95Q43993357-C50EBA5A-19B3-450D-B8B2-A0D6355F9E59Q44329316-82FD133B-52C9-43AA-84C1-0C6988F5B34CQ45876765-E7575EC1-0D84-48BC-A05A-E06E13A2DE9E
P2860
Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Genotyping of hepatitis C viru ...... epidemiological applications.
@en
type
label
Genotyping of hepatitis C viru ...... epidemiological applications.
@en
prefLabel
Genotyping of hepatitis C viru ...... epidemiological applications.
@en
P2093
P356
P1476
Genotyping of hepatitis C viru ...... epidemiological applications.
@en
P2093
Nordenfelt E
Norkrans G
P304
P356
10.1002/JMV.1890440311
P50
P577
1994-11-01T00:00:00Z